• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Chronic Graft Versus Host Disease

Chronic Graft Versus Host Disease - 29 Studies Found

Completed : A Phase II Trial of Low-Dose Interleukin-2 (IL-2) Added to Extra-Corporeal Photopheresis for Steroid-Refractory Chronic Graft-versus-Host-Disease
: Chronic Graft-versus-host-disease
: 2015-01-07
:
  • Procedure: Extracorporeal Photopheresis (ECP)

Completed : Treatment of Chronic Graft-Versus-Host Disease With Mesenchymal Stromal Cells
: Chronic Graft-Versus-Host Disease
: 2014-11-05
: Biological: Mesenchymal Stromal Cells Mesenchymal stem cell(MSC). Patients with newly diagnosed cGvHD: p
Completed : Rituximab for the Primary Treatment of Denovo Extensive Chronic Graft Versus Host Disease (GVHD)
: Chronic Graft-versus-host Disease
: 2010-07-12
: Drug: Rituximab Rituximab 375 mg/m2/dose x 4 weekly doses on days 1, 8, 15 and 22 and then at 3, 6, 9 an
Terminated : Positron Emission Tomography - Computed Tomography (PET-CT) Scanning in Chronic Graft Versus Host Disease (cGvHD)
: Chronic Graft Versus Host Disease
: 2010-12-01
: Other: PET-CT Scan PET-CT scan will be done at baseline (per standard of care), at onset and confirmatio
Terminated : Mesenchymal Stem Cells for Treatment of Refractory Chronic Graft-versus-host Disease
: Chronic Graft-versus-host Disease
: 2013-01-05
:
  • Biological: Mesenchymal stem cells

Withdrawn : A Study of Panobinostat (LBH589) as Second-Line Therapy in Patients With Chronic Graft-Versus-Host Disease
: Chronic Graft-Versus-Host Disease
: 2009-12-07
:
  • Drug: LBH589 20 mg PO three ti

Completed : Ofatumumab as Primary Therapy of Chronic Graft Versus Host Disease
: Chronic Graft Versus Host Disease
: 2012-09-04
: Drug: Ofatumumab Phase I: test an escalating dose of ofatu
Completed : A Safety and Efficacy Study of Uvadex and Extracorporeal Photopheresis (ECP) in Chronic Graft Versus Host Disease
: Chronic Graft Versus Host Disease
: 2011-06-22
:
  • Drug: ECP(Methoxsalen)+Corticosteroids+Cyclosporine or Tacrolimus

Completed : Multiple Donor Treg DLI for Severe Refractory Chronic GVHD
: Chronic Graft Versus Host Disease
: 2016-04-20
: Biological: T reg DLI Purified Treg cells will be obtained
Recruiting : Ibrutinib in Combination With Corticosteroids Versus Placebo in Combination With Corticosteroids in Subjects With New Onset Chronic Graft Versus Host Disease (cGVHD)
: Chronic Graft Versus Host Disease
: 2016-10-25
:
  • Drug: ibrutinib Ibrutinib caps

Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.